8th Annual Pharmaceutical Regulatory Affairs Asia

The current Asian regulatory environment features fast-paced changes in regulations, varied interpretation of guidelines, lack of transparency in processes and delayed timelines for approval.

The 8th annual event will address these concerns with an increased focus on crafting regulatory strategies for efficient drug approvals in each jurisdiction, as well as identifying regulatory pathways for key bioproducts across Asia .

Being up-to-date with current requirements and understanding individual authority interpretation of guidelines is critical for successful product registration.

The challenge in Asia is the frequency of changing regulations and increasing time-lags for regulatory approval – Factors which can significantly impact the time to get your products to the market, and in turn adversely affecting commercial success.